RevBits Sweeps the 2024 Globee Cybersecurity Awards Across Multiple Solutions and Categories
18.3.2024 16:00:00 EET | Business Wire | Press release
RevBits, winner in eight categories of the 2024 Globee Cybersecurity Awards®, continues to advance the state of cybersecurity solutions. The Globee Awards recognizes the world’s top providers by their organizational performance, innovations, products and services, leadership, initiatives, and more.
RevBits is pleased to be the recipient of eight awards in multiple categories.
Company-level awards:
- Silver | Most Innovative Security Company
- Silver | Cybersecurity Chief Technology Officer of the Year
Product-level awards:
- Gold | Security Platform
- Gold | Deception-based Security
- Gold | Endpoint Detection, Visibility & Response
- Silver | Privileged Access Control, Security, & Management
- Bronze | Email Security and Management
- Bronze | Zero Trust Security
“This recognition of eight awards, for our company, CTO and all six of our main product modules is extremely gratifying. It confirms both the breadth and depth of our solution is unrivaled in the crowded cybersecurity market,” said David Schiffer, CEO. “One of our tag lines is ‘Every CISO’s Dream’ and RevBits’ Cybersecurity Intelligent Platform, truly is that.”
“Innovation is at the core of everything we do,” said Mucteba Celik, CTO. “We probably have the broadest footprint of any cybersecurity software vendor in the market. And still every single one of our products has innovative and unique features that make it stand out from other mainstream solutions. We have wider coverage with superior products. We continue to innovate, for instance in 2023 we have enabled three of our solutions to be fully deployable in Air-Gapped environments (EPS&EDR, PAM, and DT solutions). Once again it is gratifying to see this validated by the experts.”
About RevBits
RevBits is a cybersecurity leader that delivers new levels of security IQ, using behavioral analysis, artificial intelligence, and machine learning, through RevBits Cyber Intelligence Platform (CIP). RevBits CIP is an extensible platform that can plug into Syslog, LogRhythm, Splunk, SIEM, and other log management and security platforms. The integrated dashboard, or mobile app, allows a CISO to see the status of all major components within their cyber defense.
RevBits is taking cybersecurity to the next level, innovating new capabilities with multiple patented technologies to ensure our competitive advantage. RevBits eliminates security gaps between siloed products that cannot integrate, correlate, or analyze unrelated alerts, logs, events, or behavior analytics. RevBits patented technology includes best-in-class cybersecurity modules and provides superior protection by seamlessly working together.
RevBits is headquartered in Mineola, NY with offices in Princeton, NJ; Boston, MA; Houston, TX; Antwerp, Belgium; and London, England. For more information on RevBits please visit www.revbits.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240318597175/en/
Contact information
Neal Hesterberg
Vice President of Business Development
RevBits
Neal.hesterberg@revbits.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva26.9.2026 02:00:00 EEST | Press release
Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva (FOP). The recommended dose of Atebrioz is 100 mg administered orally, once daily. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925436454/en/ “Today marks an important milestone for people living with FOP, bringing a new treatment option to adult and pediatric patients living with this devastating disease,” said Chris Peetz, Chief Executive Officer at Mirum. “At Mirum, we are driven to serve rare disease communities where the unmet need is significant and the opportunity to make a difference is profound. The approval of Atebrioz reflects what can be achieved when industry, researchers
Digital Reef Signs Offtake Agreement with Oreasoc Agriculture to Mitigate the Environmental Footprint of Data Centre Growth Through Rainforest Protection, Appointing Xange.com as Digital MRV Partner25.9.2026 22:19:00 EEST | Press release
At Climate Week NYC, Digital Reef and Oreasoc Agriculture Inc. sign an offtake agreement connecting Digital Reef’s 3.3 GW data centre pipeline with environmental assets exceeding 30 million hectares of South American Amazon rainforest, mitigating the environmental footprint of data centre growth through rainforest protection and restoration where Oreasoc works alongside local communities to protect biodiversity, develop sustainable economies and safeguard their territories. Xange.com are appointed as digital MRV technology partner to monitor the data centres and rainforest where Digital Reef will purchase verified environmental assets generated by Oreasoc, supporting the development of low-carbon data centres mitigating their environmental footprint through the protection of high-integrity natural ecosystems across the South American Amazon, whilst advancing sustainable economic development. AI and data centre demand is driving rapid growth, with the International Energy Agency project
NetApp Announces Intent to Acquire PEAK:AIO to Advance Scalable AI Infrastructure Architecture25.9.2026 16:00:00 EEST | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced its intent to acquire PEAK:AIO, a pioneer in next-generation metadata architecture and high-performance parallel file systems. The planned acquisition is expected to accelerate NetApp's AI infrastructure roadmap by augmenting metadata services and parallel namespace innovation designed to help AI clouds scale shared storage alongside growing GPU clusters. As AI becomes embedded in every enterprise workload, organizations are confronting a new challenge: traditional storage architectures were not designed for the unprecedented scale, concurrency, and performance requirements of AI factories, AI clouds, and next-generation data-intensive applications. NetApp is building an architecture that disaggregates metadata from data and enables metadata services to scale independently, creating a foundation for AI infrastructure capable of supporting trillions of files, exabyte-scale environments, and massively pa
MultiBank Group Secures Two Awards at Forex Expo Dubai 202625.9.2026 15:57:00 EEST | Press release
MultiBank Group, one of the world’s largest financial derivatives institutions, received two awards during its participation at Forex Expo Dubai 2026, held on 22 and 23 September at Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925539591/en/ MultiBank Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The first award recognised the strength and breadth of MultiBank Group’s global institutional offering, which brings together trading, liquidity, technology, infrastructure, execution, market access and tailored client solutions within an integrated financial ecosystem. The second award acknowledg
Croma-Pharma Introduces saypha ® volume prime Lidocaine25.9.2026 15:04:00 EEST | Press release
Croma-Pharma introduces saypha® volume prime Lidocaine, a cross-linked hyaluronic acid dermal filler that replaces saypha® volume Lidocaine within the company's saypha® portfolio. The new product offers physicians a more versatile solution with expanded indications for both midface volumization and nasolabial folds, backed by strong clinical data. 1,2 saypha® volume prime Lidocaine demonstrated non-inferiority to comparatora in a randomized, subject- and evaluator-blinded, controlled, non-inferiority multicenter, parallel group comparison study with almost 500 patients.2 In the clinical evaluation, a high patient satisfaction highlights improved midface fullness, smoothness and contour, consistent with a rheologic profile designed to provide volumization in the mobile midface.b,2 With saypha® volume prime Lidocaine, Croma-Pharma further strengthens its product range, reflecting the company's long-standing commitment to scientific excellence and continuous product innovation, and provid
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom